LSNE completes expansion to meet validated storage and cold chain options

By Maggie Lynch

- Last updated on GMT

(Image: Getty/ 10174593_258)
(Image: Getty/ 10174593_258)

Related tags Cold chain Quality control cGMP Gmp Manufacturing analytical

Growing need for validated storage capacity sees Lyophilization Services of New England complete an expansion its cGMP storage capabilities at its New Hampshire site.

Lyophilization Services of New England (LSNE), a contract development and manufacturing organization (CDMO), continues its ongoing expansion at its Bedford, New Hampshire site, adding increased short- and long-term current good manufacturing practice (cGMP) storage capabilities. The expanded facility meets the requirements of controlled room temperature, refrigerated, and frozen temperature-sensitive products.

Additionally, the growth project has added ICH stability chambers for standard storage conditions including -20°C, 2-8°C, 25°C/60%RH, 30°C/65%RH, 40°C/75%RH.

Jeff Clement, VP of business development at LSNE, told Outsourcing-Pharma, “More and more of our clients told us that they sometimes struggle finding long term validated storage options. Our capacity was limited, so this increase in validated storage space it already working out very well for our existing clients.”

The Bedford site also houses LSNE’s quality control laboratory for analytical and microbiology testing services. With the addition of the cGMP storage capabilities at the site, LSNE said it will be able to provide a solution to address its clients’ cold chain storage requirements.

Shawn Cain, COO at LSNE, said, “Having 80,000 cubic feet of additional on-site cGMP temperature-controlled storage will ensure products reaching patients around the world are stored properly. We understand dependable storage is critical to our clients' products.”

Aside from its four New Hampshire facilities, LSNE has sites in Wisconsin and Spain.

Related news

Related products

show more

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

Designing an Optimal APAC Clinical Supply Chain

Designing an Optimal APAC Clinical Supply Chain

Catalent | 08-Mar-2023 | Infographic

With clinical study activity increasing across the Asia-Pacific region, it is important for sponsors—both in APAC and globally—to understand the broader...

Related suppliers

Follow us

Products

View more

Webinars